Advanced search
Publication Cover
Journal of the American Statistical Association Volume 108, 2013 - Issue 502
Submit an article Journal homepage
4,338
Views
105
CrossRef citations to date
0
Altmetric
Theory and Methods

Effectively Selecting a Target Population for a Future Comparative Study

Lihui Zhao Department of Preventive Medicine, Northwestern University, Chicago, IL, 60611, USA
,
Lu Tian Department of Health Research and Policy, Stanford University, Stanford, CA, 94305, USA
,
Tianxi Cai Department of Biostatistics, Harvard University, Boston, MA, 02115, USA
,
Brian Claggett Division of Cardiovascular Medicine, Harvard Medical School, Boston, MA, 02115, USA
&
L. J. Wei Department of Biostatistics, Harvard University, Boston, MA, 02115, USA
Pages 527-539 | Received 01 Aug 2011, Published online: 01 Jul 2013

Citations (105)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (12)

Xiang Peng & Huixia Judy Wang. (2022) A Generalized Quantile Tree Method for Subgroup Identification. Journal of Computational and Graphical Statistics 31:3, pages 824-834.
Read now
Steve Yadlowsky, Fabio Pellegrini, Federica Lionetto, Stefan Braune & Lu Tian. (2021) Estimation and Validation of Ratio-based Conditional Average Treatment Effects Using Observational Data. Journal of the American Statistical Association 116:533, pages 335-352.
Read now
Juan Shen & Annie Qu. (2020) Subgroup analysis based on structured mixed-effects models for longitudinal data. Journal of Biopharmaceutical Statistics 30:4, pages 607-622.
Read now
Bernhard Haller, Hans-Henning Eckstein, Peter A. Ringleb & Kurt Ulm. (2019) Investigation of age–treatment interaction in the SPACE trial using different statistical approaches. Journal of Applied Statistics 46:9, pages 1689-1701.
Read now
Aniek Sies, Koen Demyttenaere & Iven Van Mechelen. (2019) Studying treatment-effect heterogeneity in precision medicine through induced subgroups. Journal of Biopharmaceutical Statistics 29:3, pages 491-507.
Read now
Kristina S Chen, Jipan Xie, Wenxi Tang, Jing Zhao, Palle B Jeppesen & James E Signorovitch. (2018) Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel syndrome. Therapeutics and Clinical Risk Management 14, pages 1267-1277.
Read now
Kevin Doubleday, Hua Zhou, Haoda Fu & Jin Zhou. (2018) An Algorithm for Generating Individualized Treatment Decision Trees and Random Forests. Journal of Computational and Graphical Statistics 27:4, pages 849-860.
Read now
Ailin Fan, Rui Song & Wenbin Lu. (2017) Change-Plane Analysis for Subgroup Detection and Sample Size Calculation. Journal of the American Statistical Association 112:518, pages 769-778.
Read now
Changyu Shen, Xiaochun Li & Jaesik Jeong. (2016) Estimation of treatment effect in a subpopulation: An empirical Bayes approach. Journal of Biopharmaceutical Statistics 26:3, pages 507-518.
Read now
Thomas Ondra, Alex Dmitrienko, Tim Friede, Alexandra Graf, Frank Miller, Nigel Stallard & Martin Posch. (2016) Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review. Journal of Biopharmaceutical Statistics 26:1, pages 99-119.
Read now
Juan Shen & Xuming He. (2015) Inference for Subgroup Analysis With a Structured Logistic-Normal Mixture Model. Journal of the American Statistical Association 110:509, pages 303-312.
Read now
Tingting Cai & Tao Hu. Subgroup detection in the heterogeneous partially linear additive Cox model. Journal of Nonparametric Statistics 0:0, pages 1-26.
Read now

Articles from other publishers (93)

Tingting Cai, Jianbo Li, Qin Zhou, Songlou Yin & Riquan Zhang. (2024) Subgroup detection based on partially linear additive individualized model with missing data in response. Computational Statistics & Data Analysis 192, pages 107910.
Crossref
Pan Liu & Jialiang Li. (2023) Segment regression model average with multiple threshold variables and multiple structural breaks. Canadian Journal of Statistics 52:1, pages 131-161.
Crossref
Menglan Pang, Audrey Gabelle, Paramita Saha‐Chaudhuri, Willem Huijbers, Arie Gafson, Paul M. Matthews, Lu Tian, Ivana Rubino, Richard Hughes, Carl de Moor, Shibeshih Belachew & Changyu Shen. (2023) Precision medicine analysis of heterogeneity in individual‐level treatment response to amyloid beta removal in early Alzheimer's disease. Alzheimer's & Dementia 20:2, pages 1102-1111.
Crossref
Na Bo, Yue Wei, Lang Zeng, Chaeryon Kang & Ying Ding. (2024) A Meta-Learner Framework to Estimate Individualized Treatment Effects for Survival Outcomes. Journal of Data Science, pages 1-19.
Crossref
Sophie Sun, Konstantinos Sechidis, Yao Chen, Jiarui Lu, Chong Ma, Ardalan Mirshani, David Ohlssen, Marc Vandemeulebroecke & Björn Bornkamp. (2022) Comparing algorithms for characterizing treatment effect heterogeneity in randomized trials. Biometrical Journal 66:1.
Crossref
Tomas Kalincik, Izanne Roos & Sifat Sharmin. (2023) Observational studies of treatment effectiveness in neurology. Brain 146:12, pages 4799-4808.
Crossref
Boyi Guo, Hannah D. Holscher, Loretta S. Auvil, Michael E. Welge, Colleen B. Bushell, Janet A. Novotny, David J. Baer, Nicholas A. Burd, Naiman A. Khan & Ruoqing Zhu. (2021) Estimating Heterogeneous Treatment Effect on Multivariate Responses Using Random Forests. Statistics in Biosciences 15:3, pages 545-561.
Crossref
Kaveh Jafari, Ali Özduran & Mehmet Bahri Saydam. (2021) Hospitality and tourism industry amid COVID-19 pandemic: voices from small Mediterranean town. International Hospitality Review 37:2, pages 243-264.
Crossref
Joseph Mwangi Njuguna & Gilbert Nyaga Njagi. (2023) Effect of Microfinance Practices on Growth of the Bodaboda Industry in Kenya; A Case of Kamukunji Sub-County. Journal of Business Management and Economic Development 1:03, pages 540-555.
Crossref
Hiroko H. Dodge & Steven E. Arnold. (2023) One step forward to personalized medicine?. Alzheimer's & Dementia: Translational Research & Clinical Interventions 9:4.
Crossref
Peng Jin, Wenbin Lu, Yu Chen & Mengling Liu. (2023) Change-Plane Analysis for Subgroup Detection with a Continuous Treatment. Biometrics 79:3, pages 1920-1933.
Crossref
Dana Johnson, Wenbin Lu & Marie Davidian. (2023) A General Framework for Subgroup Detection via One-Step Value Difference Estimation. Biometrics 79:3, pages 2116-2126.
Crossref
Maria Pia Sormani, Jeremy Chataway, David M Kent & Ruth Ann Marrie. (2023) Assessing heterogeneity of treatment effect in multiple sclerosis trials. Multiple Sclerosis Journal 29:9, pages 1158-1161.
Crossref
Xiaotong Jiang, Gabrielle Simoneau, Mel Zuercher, Yanic Heer, Philip van Hoevell, Adrian Harrington, Wanda Castro-Borrero, Carl de Moor, Fabio Pellegrini, Lu Tian, Arnfin Bergmann & Stefan Braune. (2023) Overall and patient-specific comparative effectiveness of dimethyl fumarate versus teriflunomide: A novel approach to precision medicine applied to the German NeuroTrans Data Multiple Sclerosis Registry. Multiple Sclerosis Journal - Experimental, Translational and Clinical 9:3.
Crossref
Shengli An, Peter Zhang & Hong-Bin Fang. (2023) Subgroup Identification in Survival Outcome Data Based on Concordance Probability Measurement. Mathematics 11:13, pages 2855.
Crossref
Layla Parast, Tianxi Cai & Lu Tian. (2022) Using a surrogate with heterogeneous utility to test for a treatment effect. Statistics in Medicine 42:1, pages 68-88.
Crossref
Sergio Venturini, Marco Bonetti, Ann A. Lazar, Bernard F. Cole, Xin Victoria Wang, Richard D. Gelber & Wai-Ki Yip. (2022) Subpopulation Treatment Effect Pattern Plot (STEPP) Methods with R and Stata. Journal of Data Science, pages 106-126.
Crossref
Alexis L. Angelette, Adrienne M. Murphy, Fatima Iqbal, Cade Bourgeois, Grant Borne, Lauren Rando, Elyse M. Cornett & Alan David Kaye. 2023. Substance Use and Addiction Research. Substance Use and Addiction Research 55 64 .
Hongwei Wang, Dai Feng & Yingyi Liu. 2023. Real-World Evidence in Medical Product Development. Real-World Evidence in Medical Product Development 289 320 .
Ryo Iketani & Keiko Konomura. (2022) Identification of individuals benefiting from the kakaritsuke-yakuzaishi (family pharmacist) system in Japan: a retrospective cohort study using an employment-based health insurance claims database. BMC Health Services Research 22:1.
Crossref
Baojiang Chen, Ao Yuan & Jing Qin. (2021) Pool adjacent violators algorithm–assisted learning with application on estimating optimal individualized treatment regimes. Biometrics 78:4, pages 1475-1488.
Crossref
Xin Huang, Lu Tian, Yan Sun, Saptarshi Chatterjee & Viswanath Devanarayan. (2022) Predictive signature development based on maximizing the area between receiver operating characteristic curves. Statistics in Medicine 41:26, pages 5242-5257.
Crossref
Shahrukh Shar, Zaeem Inayat, Muhammad Haris & Muhammad Anas Buksh. (2022) Improving Supply Chain Performance: A Case Study of Interwood Mobel. South Asian Journal of Operations and Logistics, pages 53-64.
Crossref
Jean-Pierre R. Falet, Joshua Durso-Finley, Brennan Nichyporuk, Julien Schroeter, Francesca Bovis, Maria-Pia Sormani, Doina Precup, Tal Arbel & Douglas Lorne Arnold. (2022) Estimating individual treatment effect on disability progression in multiple sclerosis using deep learning. Nature Communications 13:1.
Crossref
Xu Gao, Weining Shen, Jing Ning, Ziding Feng & Jianhua Hu. (2021) Addressing patient heterogeneity in disease predictive model development. Biometrics 78:3, pages 1045-1055.
Crossref
Chafic Karam, Duncan Brown, Min Yang, Nicolae Done, Ibou Dieye, Ana Bozas, Montserrat Vera Llonch & James Signorovitch. (2022) Factors associated with increased health‐related quality‐of‐life benefits in hereditary transthyretin amyloidosis polyneuropathy patients treated with inotersen . Muscle & Nerve 66:3, pages 319-328.
Crossref
Can Cui, Jiangwei Sun, Kyla A. McKay, Caroline Ingre & Fang Fang. (2022) Medication use and risk of amyotrophic lateral sclerosis—a systematic review. BMC Medicine 20:1.
Crossref
Kevin Doubleday, Jin Zhou, Hua Zhou & Haoda Fu. (2021) Risk controlled decision trees and random forests for precision Medicine. Statistics in Medicine 41:4, pages 719-735.
Crossref
Marjan Mohammadzadeh, Asra Taras & Christiane Stock. (2023) Participant recruitment among vulnerable populations: An experience from a qualitative study among refugee adolescents in Germany. Open Research Europe 2, pages 47.
Crossref
Marjan Mohammadzadeh, Asra Taras & Christiane Stock. (2022) Participant recruitment among vulnerable populations: An experience from a qualitative study among refugee adolescents in Germany. Open Research Europe 2, pages 47.
Crossref
Michael J. Grayling, Theophile Bigirumurame, Svetlana Cherlin, Luke Ouma, Haiyan Zheng & James M. S. Wason. (2021) Innovative trial approaches in immune-mediated inflammatory diseases: current use and future potential. BMC Rheumatology 5:1.
Crossref
Jeroen Hoogland, Joanna IntHout, Michail Belias, Maroeska M. Rovers, Richard D. Riley, Frank E. Harrell Jr, Karel G. M. Moons, Thomas P. A. Debray & Johannes B. Reitsma. (2021) A tutorial on individualized treatment effect prediction from randomized trials with a binary endpoint. Statistics in Medicine 40:26, pages 5961-5981.
Crossref
Victor B. Talisa & Chung‐Chou H. Chang. (2021) Learning and confirming a class of treatment responders in clinical trials. Statistics in Medicine 40:22, pages 4872-4889.
Crossref
Jialiang Li, Yaguang Li, Baisuo Jin & Michael R. Kosorok. (2021) Multithreshold change plane model: Estimation theory and applications in subgroup identification. Statistics in Medicine 40:15, pages 3440-3459.
Crossref
Zhanglin Lin Cui, Zbigniew Kadziola, Ilya Lipkovich, Douglas E Faries, Kristin M Sheffield & Gebra Cuyun Carter. (2021) Predicting optimal treatment regimens for patients with HR+/HER2- breast cancer using machine learning based on electronic health records. Journal of Comparative Effectiveness Research 10:9, pages 777-795.
Crossref
Ying Huang, Juhee Cho & Youyi Fong. (2021) Threshold-Based Subgroup Testing in Logistic Regression Models in Two-Phase Sampling Designs. Journal of the Royal Statistical Society Series C: Applied Statistics 70:2, pages 291-311.
Crossref
Francesca Bovis, Tomas Kalincik, Fred LublinGary CutterCharles MalpasDana HorakovaEva Kubala HavrdovaMaria TrojanoAlexandre PratMarc GirardPierre DuquetteMarco OnofrjAlessandra LugaresiGuillermo IzquierdoSara EichauFrancesco PattiMurat TerziPierre GrammondRoberto BergamaschiPatrizia SolaDiana FerraroSerkan OzakbasGerardo IulianoCavit BozRaymond HuppertsFrancois Grand'MaisonCelia Oreja-GuevaraVincent van Pesch, Elisabetta CartechiniThor PetersenAyse AltintasAysun SoysalCristina Ramo-TelloPamela McCombeRecai TurkogluHelmut ButzkuevenJerry S. Wolinsky, Claudio Solaro & Maria Pia Sormani. (2021) Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a. Neurology 96:2.
Crossref
Victor B. Talisa & Chung-Chou H. Chang. 2021. Data Science: Theory and Applications. Data Science: Theory and Applications 155 199 .
Durga Prasanna Misra, Olena Zimba & Armen Yuri Gasparyan. (2020) Statistical data presentation: a primer for rheumatology researchers. Rheumatology International 41:1, pages 43-55.
Crossref
Pingye Zhang, Junshui Ma, Xinqun Chen & Yue Shentu. (2020) A nonparametric method for value function guided subgroup identification via gradient tree boosting for censored survival data. Statistics in Medicine 39:28, pages 4133-4146.
Crossref
Alexandros Rekkas, Jessica K. Paulus, Gowri Raman, John B. Wong, Ewout W. Steyerberg, Peter R. Rijnbeek, David M. Kent & David van Klaveren. (2020) Predictive approaches to heterogeneous treatment effects: a scoping review. BMC Medical Research Methodology 20:1.
Crossref
Baosheng Liang, Peng Wu, Xingwei Tong & Yanping Qiu. (2020) Regression and subgroup detection for heterogeneous samples. Computational Statistics 35:4, pages 1853-1878.
Crossref
Svetlana Cherlin & James M. S. Wason. (2020) Developing and testing high‐efficacy patient subgroups within a clinical trial using risk scores. Statistics in Medicine 39:24, pages 3285-3298.
Crossref
Tri-Long Nguyen, Gary S. Collins, Paul Landais & Yannick Le Manach. (2020) Counterfactual clinical prediction models could help to infer individualized treatment effects in randomized controlled trials—An illustration with the International Stroke Trial. Journal of Clinical Epidemiology 125, pages 47-56.
Crossref
Fabio Pellegrini, Massimiliano Copetti, Francesca Bovis, David Cheng, Robert Hyde, Carl de Moor, Bernd C Kieseier & Maria Pia Sormani. (2019) A proof-of-concept application of a novel scoring approach for personalized medicine in multiple sclerosis. Multiple Sclerosis Journal 26:9, pages 1064-1073.
Crossref
Mohsen Sadatsafavi, Mohammad Ali Mansournia & Paul Gustafson. (2020) A threshold‐free summary index for quantifying the capacity of covariates to yield efficient treatment rules. Statistics in Medicine 39:9, pages 1362-1373.
Crossref
David M. Kent, David van Klaveren, Jessica K. Paulus, Ralph D'Agostino, Steve Goodman, Rodney Hayward, John P.A. Ioannidis, Bray Patrick-Lake, Sally Morton, Michael Pencina, Gowri Raman, Joseph S. Ross, Harry P. Selker, Ravi Varadhan, Andrew Vickers, John B. Wong & Ewout W. Steyerberg. (2019) The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration. Annals of Internal Medicine 172:1, pages W1.
Crossref
Xin Huang, Yihua Gu, Yan Sun & Ivan S. F. Chan. 2020. Design and Analysis of Subgroups with Biopharmaceutical Applications. Design and Analysis of Subgroups with Biopharmaceutical Applications 245 270 .
Richard Simon. (2019) Review of Statistical Methods for Biomarker-Driven Clinical Trials. JCO Precision Oncology:3, pages 1-9.
Crossref
Francesca Bovis, Luca Carmisciano, Alessio Signori, Matteo Pardini, Joshua R. Steinerman, Thomas Li, Aaron P. Tansy & Maria Pia Sormani. (2019) Defining responders to therapies by a statistical modeling approach applied to randomized clinical trial data. BMC Medicine 17:1.
Crossref
Raphaël Porcher, Justine Jacot, Jay S Wunder & David J Biau. (2018) Identifying treatment responders using counterfactual modeling and potential outcomes. Statistical Methods in Medical Research 28:10-11, pages 3346-3362.
Crossref
Gerd Rosenkranz. 2019. Exploratory Subgroup Analyses in Clinical Research. Exploratory Subgroup Analyses in Clinical Research 197 215 .
Cynthia Huber, Norbert Benda & Tim Friede. (2019) A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations. Pharmaceutical Statistics 18:5, pages 600-626.
Crossref
Tyler J. VanderWeele. (2019) The Interaction Continuum. Epidemiology 30:5, pages 648-658.
Crossref
Tyler J. VanderWeele, Alex R. Luedtke, Mark J. van der Laan & Ronald C. Kessler. (2019) Selecting Optimal Subgroups for Treatment Using Many Covariates. Epidemiology 30:3, pages 334-341.
Crossref
David M Kent, Ewout Steyerberg & David van Klaveren. (2018) Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects. BMJ, pages k4245.
Crossref
Nicolás M. Ballarini, Gerd K. Rosenkranz, Thomas Jaki, Franz König & Martin Posch. (2018) Subgroup identification in clinical trials via the predicted individual treatment effect. PLOS ONE 13:10, pages e0205971.
Crossref
Ye He, Huazhen Lin & Dongsheng Tu. (2018) A single‐index threshold Cox proportional hazard model for identifying a treatment‐sensitive subset based on multiple biomarkers. Statistics in Medicine 37:23, pages 3267-3279.
Crossref
Jingxiang Chen, Haoda Fu, Xuanyao He, Michael R. Kosorok & Yufeng Liu. (2018) Estimating Individualized Treatment Rules for Ordinal Treatments. Biometrics 74:3, pages 924-933.
Crossref
Shu-Chih Su, Xiaoming Li, Yanli Zhao & Ivan S. F. Chan. (2017) Population-Enrichment Adaptive Design Strategy for an Event-Driven Vaccine Efficacy Trial. Statistics in Biosciences 10:2, pages 357-370.
Crossref
Veronika Skrivankova & Patrick J. Heagerty. (2018) Single Index Methods for Evaluation of Marker-guided Treatment Rules Based on Multivariate Marker Panels. Biometrics 74:2, pages 663-672.
Crossref
Richard M. Simon. (2018) Personalized Cancer Genomics. Annual Review of Statistics and Its Application 5:1, pages 169-182.
Crossref
Nichole Andrews & Hyunkeun Cho. (2017) Validating effectiveness of subgroup identification for longitudinal data. Statistics in Medicine 37:1, pages 98-106.
Crossref
Suhyun KangWenbin Lu & Rui Song. (2017) Subgroup detection and sample size calculation with proportional hazards regression for survival data. Statistics in Medicine 36:29, pages 4646-4659.
Crossref
Shuai Chen, Lu Tian, Tianxi Cai & Menggang Yu. (2017) A General Statistical Framework for Subgroup Identification and Comparative Treatment Scoring. Biometrics 73:4, pages 1199-1209.
Crossref
Caiyun Fan, Wenbin Lu, Rui Song & Yong Zhou. (2017) Concordance-Assisted Learning for Estimating Optimal Individualized Treatment Regimes. Journal of the Royal Statistical Society Series B: Statistical Methodology 79:5, pages 1565-1582.
Crossref
Xiaofei Bai, Anastasios A. Tsiatis, Wenbin Lu & Rui Song. (2016) Optimal treatment regimes for survival endpoints using a locally-efficient doubly-robust estimator from a classification perspective. Lifetime Data Analysis 23:4, pages 585-604.
Crossref
Runchao Jiang, Wenbin Lu, Rui Song & Marie Davidian. (2017) On Estimation of Optimal Treatment Regimes for Maximizing t -Year Survival Probability . Journal of the Royal Statistical Society Series B: Statistical Methodology 79:4, pages 1165-1185.
Crossref
Haoda Fu & Jin Zhou. (2017) A unified approach for subgroup identification and individualized treatment recommendation with applications to randomized control trials and observational studies. Model Assisted Statistics and Applications 12:3, pages 287-301.
Crossref
Wentian Guo, Yuan Ji & Daniel V. T. Catenacci. (2017) A Subgroup Cluster-Based Bayesian Adaptive Design for Precision Medicine. Biometrics 73:2, pages 367-377.
Crossref
Paul Delmar, Cornelia Irl & Lu Tian. (2017) Innovative methods for the identification of predictive biomarker signatures in oncology: Application to bevacizumab. Contemporary Clinical Trials Communications 5, pages 107-115.
Crossref
Maria Trojano, Mar Tintore, Xavier Montalban, Jan Hillert, Tomas Kalincik, Pietro Iaffaldano, Tim Spelman, Maria Pia Sormani & Helmut Butzkueven. (2017) Treatment decisions in multiple sclerosis — insights from real-world observational studies. Nature Reviews Neurology 13:2, pages 105-118.
Crossref
Ilya LipkovichAlex DmitrienkoRalph B.D'AgostinoD'Agostino. (2016) Tutorial in biostatistics: data‐driven subgroup identification and analysis in clinical trials. Statistics in Medicine 36:1, pages 136-196.
Crossref
Yuanyuan Shen & Tianxi Cai. (2016) Identifying Predictive Markers for Personalized Treatment Selection. Biometrics 72:4, pages 1017-1025.
Crossref
Florence H. Yong, Lu Tian, Sheng Yu, Tianxi Cai & L. J. Wei. (2016) Optimal stratification in outcome prediction using baseline information. Biometrika 103:4, pages 817-828.
Crossref
Changyu Shen, Yang Hu, Xiaochun Li, Yadong Wang, Peng‐Sheng Chen & Alfred E. Buxton. (2016) Identification of subpopulations with distinct treatment benefit rate using the Bayesian tree. Biometrical Journal 58:6, pages 1357-1375.
Crossref
Xin Victoria WangBernard ColeMarco Bonetti & Richard D. Gelber. (2016) Meta‐STEPP: subpopulation treatment effect pattern plot for individual patient data meta‐analysis. Statistics in Medicine 35:21, pages 3704-3716.
Crossref
Ruo‐fan Wu, Ming Zheng & Wen Yu. (2016) Subgroup Analysis with Time‐to‐Event Data Under a Logistic‐Cox Mixture Model. Scandinavian Journal of Statistics 43:3, pages 863-878.
Crossref
Junlong Li, Lihui Zhao, Lu Tian, Tianxi Cai, Brian Claggett, Andrea Callegaro, Benjamin Dizier, Bart Spiessens, Fernando Ulloa-Montoya & Lee-Jen Wei. (2016) A Predictive Enrichment Procedure to Identify Potential Responders to a New Therapy for Randomized, Comparative Controlled Clinical Studies. Biometrics 72:3, pages 877-887.
Crossref
Stuart G. Baker & Marco Bonetti. (2016) Evaluating Markers for Guiding Treatment. Journal of the National Cancer Institute 108:9, pages djw101.
Crossref
Haoda FuJin ZhouDouglas E. Faries. (2016) Estimating optimal treatment regimes via subgroup identification in randomized control trials and observational studies. Statistics in Medicine 35:19, pages 3285-3302.
Crossref
Ying Huang & Eric Laber. (2014) Personalized Evaluation of Biomarker Value: A Cost-Benefit Perspective. Statistics in Biosciences 8:1, pages 43-65.
Crossref
Dimitris Bertsimas, Allison O’Hair, Stephen Relyea & John Silberholz. (2016) An Analytics Approach to Designing Combination Chemotherapy Regimens for Cancer. Management Science 62:5, pages 1511-1531.
Crossref
Richard Simon. 2014. Wiley StatsRef: Statistics Reference Online. Wiley StatsRef: Statistics Reference Online 1 7 .
Xiwen Ma, Wei Zheng & Yuefeng Lu. 2016. Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics. Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics 91 104 .
Juliana Setyawan, Hongbo Yang, David Cheng, Xiaopeng Cai, James Signorovitch, Jipan Xie & M. Haim Erder. (2015) Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder. Value in Health 18:6, pages 824-831.
Crossref
Stuart G Baker & Barnett S Kramer. (2014) Evaluating surrogate endpoints, prognostic markers, and predictive markers: Some simple themes. Clinical Trials 12:4, pages 299-308.
Crossref
Rui WangDavid A. SchoenfeldBettina HoeppnerA. Eden Evins. (2015) Detecting treatment‐covariate interactions using permutation methods. Statistics in Medicine 34:12, pages 2035-2047.
Crossref
Y. Huang, E. B. Laber & H. Janes. (2014) Characterizing expected benefits of biomarkers in treatment selection. Biostatistics 16:2, pages 383-399.
Crossref
B. Claggett, L. Tian, D. Castagno & L.-J. Wei. (2014) Treatment selections using risk-benefit profiles based on data from comparative randomized clinical trials with multiple endpoints. Biostatistics 16:1, pages 60-72.
Crossref
Roland A. MatsouakaJunlong LiTianxi Cai. (2014) Evaluating marker‐guided treatment selection strategies. Biometrics 70:3, pages 489-499.
Crossref
Tyler J. VanderWeele & Mirjam J. Knol. (2014) Interactions and Complexity: Goals and Limitations. Epidemiologic Methods 3:1.
Crossref
Tyler J. VanderWeele & Mirjam J. Knol. (2014) A Tutorial on Interaction. Epidemiologic Methods 3:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.